- Home
- CUBI vs QDEL Comparison
CUBI vs QDEL Comparison
Compare CUBI & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUBI
- QDEL
- Stock Information
- Founded
- CUBI 1994
- QDEL 1979
- Country
- CUBI United States
- QDEL United States
- Employees
- CUBI N/A
- QDEL N/A
- Industry
- CUBI Major Banks
- QDEL Medical Specialities
- Sector
- CUBI Finance
- QDEL Health Care
- Exchange
- CUBI Nasdaq
- QDEL Nasdaq
- Market Cap
- CUBI 2.3B
- QDEL 1.9B
- IPO Year
- CUBI 2012
- QDEL N/A
- Fundamental
- Price
- CUBI $67.64
- QDEL $28.70
- Analyst Decision
- CUBI Buy
- QDEL Buy
- Analyst Count
- CUBI 8
- QDEL 7
- Target Price
- CUBI $69.25
- QDEL $42.57
- AVG Volume (30 Days)
- CUBI 299.2K
- QDEL 1.2M
- Earning Date
- CUBI 10-30-2025
- QDEL 08-05-2025
- Dividend Yield
- CUBI N/A
- QDEL N/A
- EPS Growth
- CUBI N/A
- QDEL N/A
- EPS
- CUBI 4.05
- QDEL N/A
- Revenue
- CUBI $596,459,000.00
- QDEL $2,741,600,000.00
- Revenue This Year
- CUBI $16.04
- QDEL N/A
- Revenue Next Year
- CUBI $6.11
- QDEL $3.40
- P/E Ratio
- CUBI $17.42
- QDEL N/A
- Revenue Growth
- CUBI N/A
- QDEL N/A
- 52 Week Low
- CUBI $40.75
- QDEL $22.05
- 52 Week High
- CUBI $72.51
- QDEL $49.45
- Technical
- Relative Strength Index (RSI)
- CUBI 51.34
- QDEL 60.25
- Support Level
- CUBI $70.02
- QDEL $26.81
- Resistance Level
- CUBI $72.51
- QDEL $28.84
- Average True Range (ATR)
- CUBI 1.65
- QDEL 1.11
- MACD
- CUBI -0.08
- QDEL 0.24
- Stochastic Oscillator
- CUBI 33.47
- QDEL 89.27
About CUBI Customers Bancorp Inc
Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.